Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Disease sites
  • Breast
  • Cancer research investment

Cancer research investment

  • Charts and Tables

    Charts and Tables

    Figure 6.6

    Comparison of the relative burden of disease to the relative investment in research by disease site: Distribution of cancer research investment (2013), new cancer cases (2012) and cancer deaths (2011), by disease site, Canada

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “Other” refers to remaining primary types of cancer listed in International Classification of Diseases for

    Oncology-3. Included are all other invasive types and in situ for bladder.

    Data source: For cancer research investment: Canadian Cancer Research Alliance database.

    Data source for new cancer cases: Statistics Canada, Canadian Cancer Registry.

    Data source for cancer deaths: Statistics Canada, Vital Statistics Death Database.

    Source: CANSIM Table 103-0550 for 2012 cancer cases, CANSIM Table 102-0552 for 2011 cancer deaths.

    Data Table

    Disease SiteCancer Research Investment (%)New Cancer Cases (%)Cancer Deaths (%)
    Breast25.713.26.9
    Prostate12.711.95.1
    Lung5.913.926.5
    Colorectal6.512.412.1
    Other49.248.649.3

    + Expand Table

    “Other” refers to remaining primary types of cancer listed in International Classification of Diseases for

    Oncology-3. Included are all other invasive types and in situ for bladder.

    Data source: For cancer research investment: Canadian Cancer Research Alliance database.

    Data source for new cancer cases: Statistics Canada, Canadian Cancer Registry.

    Data source for cancer deaths: Statistics Canada, Vital Statistics Death Database.

    Source: CANSIM Table 103-0550 for 2012 cancer cases, CANSIM Table 102-0552 for 2011 cancer deaths.

  • Data specifications

    Data specifications

    Definition:

    1. Distribution of cancer-specific research funding for breast, colorectal, lung and prostate cancers
    2. Distribution of new cancer cases in Canada
    3. Distribution of cancer deaths in Canada

    Numerator:

    1. Investment: Amount of site-specific research investment (in dollars) for breast, prostate, lung, colorectal, or other cancers
    2. New cancer cases: Number of site-specific cases for breast, prostate, lung, colorectal, or other cancers
    3. Cancer deaths: Number of site-specific deaths from breast, prostate, lung, colorectal, or other cancers

    Denominator:

    1. Investment: Total amount of site-specific cancer research investment (in dollars)
    2. New cancer cases: Total number of new cancer cases
    3. Cancer deaths: Total number of cancer deaths

    Data source:

    1. Investment: Canadian Cancer Research Alliance, Canadian Cancer Research Survey
    2. New cases: Statistics Canada (CANSIM Table 103-0550), Canadian Cancer Registry
    3. Deaths: Statistics Canada (CANSIM Table 102-0552), Vital Statistics Death Database

    Measurement timeframe: 2013 (cancer research investment), 2012 (new cancer cases), 2011 (cancer deaths)

    Stratification variables: Disease site (breast, prostate, lung, colorectal, other)

    Notes:

    “Other” refers to the remaining primary types of cancer listed in ICD-O-3. Included are all other invasive types and in-situ for bladder.

  • Related indicators

    Related Indicators

    Adult clinical trial participation

    Ratio of adult patients (aged 19+) enrolled in clinical trials to the number of cancer incident cases of all cancers, by jurisdiction — 2012 to 2015 enrollment years
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation